This company seems to have been delisted
Reason: Went private
Last recorded trade on: December 27, 2024
Source: https://www.reuters.com/markets/deals/bansk-group-buy-petiq-15-billion-2024-08-07/
Reason: Went private
Last recorded trade on: December 27, 2024
Source: https://www.reuters.com/markets/deals/bansk-group-buy-petiq-15-billion-2024-08-07/
PetIQ
PETQ
NZ$52.87
Share price
-0.03%
Change (1 day)
88.63%
Change (1 year)
Revenue for PetIQ (PETQ)
Revenue in 2024 (TTM): NZ$1.86 Billion
According to PetIQ's latest financial reports the company's current revenue (TTM 
) is NZ$1.93 Billion. In 2023 the company made a revenue of NZ$1.74 Billion an increase over the revenue in the year 2022 that were of NZ$1.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for PetIQ from 2016 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | NZ$1.86 B | 6.99% |
| 2023 | NZ$1.74 B | 20.05% |
| 2022 | NZ$1.45 B | 6.31% |
| 2021 | NZ$1.36 B | 26.29% |
| 2020 | NZ$1.08 B | 2.63% |
| 2019 | NZ$1.05 B | 33.67% |
| 2018 | NZ$0.78 B | 109.87% |
| 2017 | NZ$0.37 B | 29.95% |
| 2016 | NZ$0.28 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | NZ$0.38 M | -99.98% | ๐บ๐ธ USA |
 OPKO Health
OPK | NZ$1.13 B | -41.46% | ๐บ๐ธ USA |